This article describes the development in the area of resin‐free acrylic pressure‐sensitive adhesive (PSA) based on 2‐ethylhexyl acrylate, methyl acrylate, acrylic acid, N‐vinyl caprolactam, and pregnancy transdermal drug delivery systems, and shows the variety of polymer composition, residue monomers content, quality control of peel adhesion level and repeating during the time, biocompatibility of the acrylic PSA layer, and efficacy in clinical medicine.
No takes yet. Share an insight, caveat, or question.
Czech et al. (2007) studied this question.
Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context: